San Carlos, California
United States
35
2020-02-13
The entities that hold a legal rights for patent applications filed by inventor SLIWKOWSKI Mark:
Mark SLIWKOWSKI from San Carlos, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
#2 | 2017-04-20METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY MAYTANSINOID CONJUGATES
#3 | 2015-04-23METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
#4 | 2014-07-31METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
#5 | 2013-08-15ErbB3 ANTIBODIES
#6 | 2013-05-02METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
#7 | 2012-01-19ErbB3 ANTIBODIES
#8 | 2011-12-01ISOFORM SPECIFIC ANTI-HER4 ANTIBODIES
#9 | 2011-06-02HUMANIZED ANTI-ERBB2 ANTIBODIES AND TREATMENT WITH ANTI-ERBB2 ANTIBODIES
#10 | 2010-12-02COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#11 | 2010-06-03METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
#12 | 2010-06-03ErbB2 and ErbB3 chimeric heteromultimer receptors
#13 | 2010-02-09ErbB2 and ErbB3 chimeric heteromultimer adhesins
#14 | 2009-08-18Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
#15 | 2009-02-12GAMMA-HEREGULIN
#16 | 2008-09-18Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
#17 | 2008-05-29Isolated Nucleic Acids, Vectors and Host Cells Encoding ErbB3 Antibodies
#18 | 2008-05-29Anti-TAT188 antibodies
#19 | 2007-10-23Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies
#20 | 2007-05-31ISOLATED NUCLEIC ACIDS, VECTORS AND HOST CELLS ENCODING ErbB3 ANTIBODIES
#21 | 2007-04-12Chimeric Heteromultimer Adhesins
#22 | 2006-09-28Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
#23 | 2006-09-07Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
#24 | 2006-08-31Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
#25 | 2006-08-29Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
#26 | 2006-08-10Inhibiting HER2 shedding with matrix metalloprotease antagonists
#27 | 2006-04-06Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
#28 | 2006-02-16Treatment with anti-ErbB2 antibody combinations
#29 | 2006-02-09γ-heregulin
#30 | 2005-10-27Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
#31 | 2005-09-27Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
#32 | 2005-09-22Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
#33 | 2005-07-12Antibodies that bind gamma-heregulin
#34 | 2005-06-23Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies
#35 | 2005-05-19Antibody compositions for the diagnosis and treatment of tumor
221920 ⎘